4//SEC Filing
Suri Anish 4
Accession 0001209191-21-060021
CIK 0001645460other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 4:00 PM ET
Size
8.8 KB
Accession
0001209191-21-060021
Insider Transaction Report
Form 4
Suri Anish
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-10-03+33,334→ 108,172 total - Exercise/Conversion
Restricted Stock Units
2021-10-03−33,334→ 0 total→ Common Stock (33,334 underlying) - Tax Payment
Common Stock
2021-10-06$12.97/sh−14,134$183,318→ 94,038 total
Footnotes (3)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Each restricted stock unit award represents a contingent right to receive one share of common stock.
- [F3]On October 3, 2019, the reporting person was granted 100,000 restricted stock units, scheduled to vest in three equal annual installments beginning on October 3, 2019.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001739130
Filing Metadata
- Form type
- 4
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 4:00 PM ET
- Size
- 8.8 KB